section against the morbidity of permanent facial weakness. Theoretically, such a test could also assist with the early identification of patients who have no hope of spontaneous FN recovery for facial reanimation procedures. Hypoglossal nerve-FN anastomosis, for example, has been shown to generate superior outcomes when performed within 6 months of nerve injury, but most wait-and-see approaches endorse at least 12 months of observation prior to reinnervation procedures. 12, 36 Among candidate tests that may be used for such predictions, EMG-based modalities have received the most attention.
The primary purpose of this study was to examine the technique of intraoperative SMS, comparing the proximal versus distal FN EMG response at the conclusion of the tumor resection with the more commonly used MST to determine if either test could prognosticate FN outcomes. Secondarily, we sought to identify patients who would experience significant permanent facial weakness, to facilitate early reanimation with the goal of improved overall functional outcome. 13 The use of intraoperative SMS testing has never been reported previously in this context.
Methods
After institutional review board approval, medical records and a prospectively maintained database of all patients who underwent microsurgery for VS at a tertiary academic referral center between September 1999 and February 2011 were identified. Initial data including previous treatments (radiotherapy or microsurgery); presence of NF2; surgical approach (retrosigmoid, middle fossa, translabyrinthine); completeness of resection as determined by the operating neurosurgeon and neurotologist; microsurgical appearance of the FN (course relative to the tumor and significant thinning or "splaying"); intraoperative EMG data (MST and SMS responses) as well as basic demographic information were recorded. Patients with < 12 months of follow-up after VS microsurgery were excluded. Additionally, patients whose FNs were known to be discontinuous following resection were excluded; that is, we only included anatomically intact nerves irrespective of their postoperative electrical stimulation status.
Aside from a short-acting induction agent, paralytics were strictly avoided throughout the operation. The intraoperative cranial nerve monitoring protocol involved placement of subdermal electroencephalography electrodes providing 4-channel continuous EMG monitoring. Data acquisition used a Viking Select (Nicolet Biomedical) EMG system. Low-frequency and high-frequency filters were set to 30 Hz and 10 kHz, respectively. Responses were conveyed on a digital oscilloscope and by a loudspeaker projected across the operating room to the surgeon. Transcutaneous bipolar electrodes were placed near the extratemporal main trunk (stylomastoid foramen region) of the FN and were used to obtain a distal response, recorded from a 5th subdermal electroencephalography electrode placed in the nasalis muscle (Fig. 1) . The distal supramaximal EMG response was obtained by delivering constant-current stimulation at 100-msec pulses increasing from 0 mA until a plateau CMAP amplitude was reached. The proximal SMS response was obtained using a monopolar Prass (Medtronic, Inc.) insulated flush-tip probe to deliver constant-current stimulation at 50-msec pulses to the root entry zone of the FN, increasing also from 0 mA until a plateau CMAP amplitude was reached. The amplitude (in mV) of the distal response was divided by the amplitude of the proximal response and the quotient was subtracted from 1; this value was multiplied by 100 to determine the percentage by which the FN function had "dropped off" proximally to distally. In other words, the formula 1 -distal response (mV)/proximal response (mV) × 100% was used to calculate percent dropoff. This dropoff can be calculated any time the proximal FN is accessible, but all of the data reported herein were obtained after efforts at resection had been completed. In addition, once all tumor resection had been completed, the FN was stimulated at the brainstem with a stimulation duration of 50 msec starting at 0 mA and increasing by 0.1-mA intervals; the lowest current at which a reliable FN response could be elicited was considered to be the MST.
The patients' FN function was assessed according to the HB scale immediately following surgery, at the time of hospital discharge, and at the most recent follow-up appointment. 13 Patients who underwent dynamic reanimation procedures were censored at the time of their reanimation; the HB grade just prior to reanimation was considered to be the last follow-up. For patients who had preoperative facial weakness, the change in HB grade was used for analysis.
Descriptive summaries were reported as the median and range for continuous variables and as frequencies and percentages for categorical variables. The association between long-term FN function as a dichotomized outcome of interest (good vs poor) and various risk factors was assessed using logistic regression. Area under the receiver operating characteristic curve, which was used as a measure of a risk factor's ability to discriminate between poor versus good outcomes, was reported. An area under the receiver operating characteristic curve estimate of 0.7-0.8 was regarded as acceptable, 0.8-0.9 was regarded as excellent, and > 0.9 was regarded as outstanding. Receiver operating characteristic curve analysis was also used to identify a potential cutoff for percent dropoff by SMS. Sensitivities and specificities were estimated based on this cutoff. All the analysis was performed using SAS version 9.2 software (SAS, Inc.). All tests were 2-sided and p values < 0.05 were considered statistically significant.
Results
Over the study period, 350 patients underwent microsurgical excision of VS at the authors' institution. There were 267 who met criteria for evaluation (55% female; mean age 48 years, range 15-86 years). Eighty-three of the 350 patients were excluded for the following reasons: 50 had a < 12-month follow-up, 28 were lost to follow-up, 4 had FN sacrifice, and 1 was affected by a concurrent enlarging FN tumor.
Tumors were right-sided in 53% of cases. The average posterior fossa tumor diameter was 24 mm (range 8-60 mm) and 54 tumors were exclusively intracanalicular. Twenty patients had undergone previous treatment prior to definitive resection at our institution; 9 had previous resection and 11 had undergone stereotactic radiation (10 with the Gamma Knife [Elekta AB] and 1 with the CyberKnife [Accuray]). Thirteen patients carried the diagnosis of NF2.
Operations were performed via a middle fossa approach in 24 cases, translabyrinthine in 87, and retrosigmoid in 156. Subtotal resection was performed in 34 cases, near-total resection in 33, and a gross-total resection was accomplished in the remaining 200.
3 Sixty-two FNs were reported to be significantly splayed at the time of surgery.
There were 5 patients who presented with FN weakness (3 with HB Grade III, 1 with Grade V, and 1 with Grade VI), and the difference between preoperative and postoperative FN function was used for their analysis. At the time of hospital discharge, 157 (59%) of the 267 patients demonstrated good (HB Grade I-II) FN function, and this improved to 222 (84%) of 265 over the long term (mean 39 months, range 12-115 months; Table 1) .
Of the 267 patients with > 12 months of follow-up and intact nerves, there were 29 who did not have adequate EMG data (neither MST nor percent dropoff by SMS) recorded at the time of resection. (Technical factors prevented the acquisition of a distal SMS response in 1 of these patients.) An additional 29 patients did not have an MST recorded. This was typically in patients with small tumors and very uncomplicated resections, and there was no concern for postoperative FN weakness in these patients. Therefore, data regarding MST were available in 209 patients. The MST values ranged from 0.1 to 10 mA at a 50-msec stimulation duration. Ninety-four percent of FNs were stimulated proximally by 1 of 3 threshold values (0.1, 0.2, or 0.3 mA at 50-msec stimulation duration). The relationship between MST and long-term FN function is demonstrated in Fig. 2 . Data sufficient to calculate a percent drop in proximal versus distal SMS were available in 172 patients. Early in our operative experience we did not routinely use this SMS technique unless we had to dissect the FN extensively. Long-term FN function is related to percent dropoff groupings in Fig. 3 . The mean proximalto-distal dropoff was 40.1% ± 27.7%, range 0%-100%).
Using univariate logistic regression to evaluate all 267 patients with adequate data for analysis of long-term FN function, factors including CPA extension, FN splaying, prior treatment, positive NF2 status, elevated MST, high proximal-to-distal dropoff by SMS, and poor FN function at the time of hospital discharge were statistically significantly associated with poor long-term FN function (Table 2) .
Comparisons between HB grade at hospital discharge and at last follow-up are summarized in Table 1 . All patients with HB Grade I-IV at the time of hospital discharge recovered to an HB Grade III or better at long-term follow-up. Additionally, patients with Grade V weakness also recovered to at least Grade III in this study, although that has not been our consistent experience over the course of our practice. Also, for statistical purposes, patients discharged with HB Grade V or VI weakness were grouped together. Interestingly, the recovery of those with severe paresis or complete paralysis (HB Grades V-VI) at discharge was much less predictable. There were 56 (21%) of 267 patients with HB Grade V or VI weakness at the time of hospital discharge. Of these 56 patients, 18 (32%) recovered to good (HB I-II) FN function. None of the factors analyzed were predictive of good FN recovery in this subset. There were 41 (73%) of 56 patients, however, who recovered at least moderate (HB I-III) FN function. We analyzed the same factors that were associated with good FN function in the entire cohort to determine if any were able to predict moderate FN function among these 56 patients discharged with significant FN weakness. The only factor statistically associated with recovery to at least HB Grade III long-term function was the percent dropoff by SMS (p = 0.04, area under the curve 0.788; Table 3 ). Among the 56 patients with HB Grade V-VI at discharge, there were 28 with data sufficient to calculate a percent dropoff by SMS. Among these 28, when a dropoff of > 75% is considered a positive test and long-term HB Grade IV-VI weakness is considered an unacceptable outcome, the sensitivity is 75%, specificity is 65%, negative predictive value is 87%, and positive predictive value is 46% (Table 4) .
Considering the 172 patients with SMS data, regardless of perioperative FN function, the percent dropoff by SMS that yields the highest sensitivity and specificity for a poor long-term FN outcome (HB Grades III-VI) is 69%. For the 34 patients who had a proximal-to-distal dropoff > 69%, the rate of poor long-term function was 44% (15 of 34). Conversely, those patients with a proximal-to-distal dropoff of ≤ 69% experienced poor FN function only 6% of the time (8 of 138 patients). Among these 172 patients, when a dropoff of > 69% is considered a positive test and long-term HB Grade III-VI weakness is considered a poor outcome, the sensitivity is 65%, specificity is 87%, negative predictive value is 94%, and positive predictive value is 44% (Table 5) .
Therefore, using intraoperative proximal-to-distal SMS data, we can counsel the patient and family in the early postoperative period regarding the long-term prognosis for good (HB Grade I-II) or moderate (HB Grade I-III) FN function, even if there is significant weakness during the postoperative hospital stay. If the proximal-todistal dropoff is ≤ 69% using the technique as we have described, the chance of good FN function long term is 94%. Additionally, if the patient awakens with or develops severe or complete FN weakness (HB Grade V-VI) in the immediate postoperative period and the proximalto-distal SMS dropoff is < 75%, there is still an approximately 50% chance of recovering to at least HB Grade III, which is as good as any dynamic facial reanimation procedure can achieve.
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Discussion
There is wide variability between intraoperative EMG monitoring protocols reported in the literature. The type of stimulating device (monopolar vs bipolar, insulated vs noninsulated) will generate distinct CMAP waveforms, with variations in amplitude and morphological features. 17 The stimulating protocol may be based on constant-voltage or constant-current techniques. 23, 27 Stimulus can be applied at threshold, suprathreshold, or supramaximal levels, as we have chosen to do over the past 11 years. 1, 19, 22 Most notably, pulse duration has a profound impact on threshold values and varies between 50 and 1000 msec. 1, 4, 6, 7, 9, 16, 18 Reporting on this parameter is inconsistent in the literature, and is even omitted from some reports. 10, 21, 22, 24, 26, 37 For example, before tumor dissection, it is very hard to get an FN response at 0.1 mA by using 50-msec stimulation duration, but just increasing the duration to 100 msec easily allows stimulation of most FNs at 0.1 mA or lower. We have chosen to use the shortest stimulation duration to minimize potential injury to the nerve.
14, 15 We increase the duration to 100 msec only while obtaining a distal supramaximal response, however, because the transcutaneous electrodes do not contact the extratemporal FN directly and a longer pulse width allows for significantly lower current levels. This does not alter the interpretation of the percent dropoff, because the proximal and distal response values are measurements of the plateaued EMG response irrespective of the current necessary to produce it.
We have used intraoperative MST and proximal-todistal SMS response dropoff using intraoperative EMG monitoring to try to prognosticate facial function outcomes in patients undergoing VS resection. To our knowledge this has not been previously reported. In our practice, the percent dropoff during SMS has emerged as the most accurate means of intraoperatively assessing the functional integrity of the FN. The results are quite evenly distributed between 0% and 100%, which affords the test excellent discriminatory capacity. This is in contrast to the MST, which has a restricted range of results, even when applied at 50-msec pulses (94% of nerves in our series had an MST of 0.1, 0.2, or 0.3 mA). We have also shown that the proximal-to-distal dropoff by SMS has a stronger association with long-term * Percentages indicate recovery according to each HB grade. Note that no patient with HB I-IV at discharge failed to recover to HB Grade III or better. † In 2 patients we could not be absolutely certain about the HB grade at last follow-up, so these patients were not included. facial function than MST. Furthermore, the percent dropoff by SMS was the only parameter we could identify that helped to predict at least moderate facial function among patients who are profoundly weak at the time of hospital discharge. This is an important consideration because the most reliable predictor of long-term facial function is perioperative facial function. Any stand-alone test applied at the conclusion of tumor removal must be able to predict long-term facial function independent of postoperative HB grade for it to be useful when counseling the patient with facial paralysis at the time of discharge whether he or she should undergo a dynamic facial reanimation procedure.
Our data suggest that only patients with HB Grade V-VI weakness are at risk for long-term facial function that is inferior to the best results obtainable by grafting techniques. That is to say, only patients discharged with HB Grade V-VI weakness are at risk for permanent HB Grade IV-VI weakness. Among the reports of 100 or more patients available in the literature, only 2 seek to apply EMG data specifically to patients with postoperative weakness. 1, 16 In the first of these reports, Axon and Ramsden 1 used MST in their patients undergoing microsurgery for VS. The authors concede that the performance characteristics of MST decrease when restricted to those patients with postoperative weakness. Furthermore, their analysis includes patients with immediate HB Grades III and IV function, which does not define the population under consideration for early dynamic reanimation because the vast majority of these patients will achieve HB Grade III or better function in the long term. When considering patients discharged with HB Grade V-VI perioperative weakness, their data do not support the prognostic role of MST used alone. In our experience there was no statistically significant relationship between MST and acceptable long-term facial function for such patients. In the second report, Isaacson et al. 16 presented data for 229 patients in whom they used stimulation thresholds and amplitudes proximal and distal to the tumor. A logistic regression equation was calculated that yields a probability for good postoperative * Prior treatment (surgery or radiation), NF2, tumor size, CPA extension, subjectively assessed FN splay, MST, percent dropoff by SMS, and HB grade at hospital discharge were all factors that had a statistically significant association with poor (HB III-VI) long-term (> 12 months) FN function. outcome. Applying the formula to patients with immediate HB Grade III-VI weakness proved to be 89% sensitive and 83% specific for predicting long-term function of HB Grade III or better. Paradoxically, the formula accuracy improved to 100% in the 11 patients with immediate HB Grade IV-VI weakness. On this basis, the authors caution interpretation of the data due to the limited number of patients. Our data, on the other hand, suggest that the MST does not add value to the proximal-to-distal amplitude ratio when the ratio is obtained by applying an SMS.
The major weakness of all electroprognostic testing lies in the inability of applied current to differentiate neurapraxia from axonotmesis and neurotmesis. 33 Therefore, no EMG technique is even theoretically reliable for predicting which patients will have long-term poor facial function. When a high percent dropoff is considered a positive test for long-term facial weakness, our data bear this out. That is, the negative predictive values for patients regardless of postoperative facial function (94%) and for those discharged with significant weakness (87%) far exceed the positive predictive values (44% and 46%, respectively). Until methods are developed to differentiate conduction block from axonal disruption among grossly intact nerves, no electrical testing modalities should have high positive predictive values for long-term weakness. Because of this inherent limitation, we believe that the relatively low sensitivities and specificities reported herein are not a shortcoming of the SMS protocol but rather an inherent limitation of EMG testing among injured but intact nerves. This is also why we do not recommend any early facial reanimation surgery that would involve anatomically disrupting the FN (for example, FN-hypoglossal nerve anastomosis), but instead wait at least 12 months from surgery to see if there will be any spontaneous recovery. In our experience this happens at least 50% of the time, even when the patient leaves the hospital with complete facial paralysis and > 75% dropoff on proximal-to-distal SMS.
Additionally, an SMS response can be obtained any time the proximal FN is accessible, which allows for intermittent use of this powerful predictive measure during the course of dissection. This might help tailor a less than gross-total resection to prevent long-term poor facial function. For example, during a difficult dissection we now commonly stimulate the FN proximally and determine SMS and percent dropoff. Once the percent dropoff approaches approximately 60% we strongly consider less-than-complete resection and avoid any additional dissection of the FN, knowing that if we can keep the dropoff of SMS to ≤ 69% there will be a 94% chance of good long-term facial function (HB Grade I-II).
Evaluating the FN with SMS eliminates many of the variables that make it difficult to compare results across institutions. Although we used an insulated monopolar electrode and a 50-msec pulse duration for intracranial stimulation, neither of those factors are relevant to the plateau maximal CMAP amplitude, which is the value used to calculate the percent dropoff. In fact, even the methods by which we obtain a distal response (bipolar transcutaneous stimulation at 100-msec pulse duration) vary markedly from the proximal stimulus, yet the quotient of proximal-to-distal remains preserved. On the other hand, MST is highly subject to institutional differences. The pulse duration has an inverse relationship to the MST and can change the threshold by an order of magnitude. Furthermore, we found that SMS was simple to perform; only 1 patient could not have a percent dropoff calculated because of technical difficulties.
Even though we were able to show a strong correlation between the percent dropoff and long-term facial function, we cannot use this test to select patients for early reinnervation procedures. A dropoff of ≤ 75% does encourage the profoundly weak patient with an 87% chance of return to at least moderate (HB Grade I-III) facial function. A similar patient with a dropoff of > 75%, however, will still recover this degree of facial function half the time. Reinnervation procedures are always limited by synkinesis, and therefore patients undergoing such rehabilitation cannot be expected to recover good (HB Grade I-II) function. So even when interrogating every transmitting axon by applying stimulus at supramaximal levels, we are still unable to predict which patients will do better with early reinnervation-either at the time of tumor resection or in the early postoperative period. Electrophysiological testing is no better at such predictions than is simply giving the nerve time to recover.
Conclusions
Preserving facial function is a priority in VS microsurgery. Among examined variables, only the proximalto-distal dropoff by SMS helped predict which patients with postoperative weakness will recover acceptable facial function in the long term. Applying SMS to the proximal and distal FN is technically simple, reliable, and safe. Patients with ≤ 69% dropoff in proximal-to-distal SMS at the conclusion of VS resection have a 94% chance of longterm FN outcome of HB Grade I-II regardless of perioperative function. The percent dropoff is a straightforward calculation and generates clinical data that are useful for counseling, but is necessarily very limited in its ability to select patients for early reinnervation procedures.
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